CaltechAUTHORS
Published April 2013 | Version public
Journal Article Metadata-only

The Effects of Broadly Neutralizing Antibodies in Experimental HCV Infection

Creators

Abstract

Hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the US. The graft is universally infected after transplantation, and this typically results in accelerated fibrosis progression. Current HCV therapies have poor efficacy and tolerability in the challenging pre- and posttransplant populations. Alternative pre- and post-transplantation measures are needed to prevent graft infection. One potential strategy to prevent such infection is the administration of potent broadly neutralizing antibodies (bnAbs).

Additional Information

© 2013 European Association for the Study of the Liver.

Additional details

Identifiers

Eprint ID
41350
Resolver ID
CaltechAUTHORS:20130916-154115267

Dates

Created
2013-09-17
Created from EPrint's datestamp field
Updated
2020-11-19
Created from EPrint's last_modified field